Inspirata today announced it has rebranded as Inspirata AI, marking a new chapter powered by enhanced, native AI-driven cancer casefinding, data abstraction, and reporting capabilities and a strengthened partnership with ONCO Inc. The updated name reflects extensive enhancements, engineering and integration work completed over the past year, resulting in a more connected, end-to-end system for cancer registry operations across the United States, Canada, and Australia.
The Inspirata AI platform leverages a proprietary native AI/NLP engine, supplemented by LLM API integrations where appropriate, to identify reportable cancer cases in real time. Through direct source connectivity and FHIR-based integration with AP-LIS, radiology, and clinical record systems, the platform analyzes source documents as they are generated, enabling timely and accurate case identification for cancer registry workflows. Through this rebrand, Inspirata AI has strengthened its integration with ONCO’s registry workflow tools, giving cancer programs a single, seamless, automated solution for casefinding through data abstraction, reporting, and data analytics, eliminating duplicate data entry and manual burden along the way.
“This rebrand represents far more than a new name. It reflects years of engineering investment in an AI engine by Inspirata AI (formerly Artificial Intelligence in Medicine -AIM) that has powered cancer registries for two decades. And now, our partnership with ONCO, provides our customers the first and only end-to-end cancer registry solution on the market,” said Satish Sanan, CEO of Inspirata AI. “Together, we’ve built a system that gives cancer registry teams earlier visibility into their clinical data and gives healthcare organizations a real strategic business advantage.”
Jim Hendrickson, Co-CEO of ONCO Inc., echoed that sentiment: “Our collaboration with Inspirata AI has never been better. By aligning our workflow expertise and our cancer registry software (cancer data management system) with their native AI-driven technology, we’re able to offer registry teams a genuine, end-to-end cancer registry solution, one where accuracy, speed, and completeness all come together.”
With 99% accuracy and significantly improved cancer registry workflow and productivity, Inspirata AI helps healthcare organizations transform cancer registry operations from a cost center into a strategic asset, supporting oncology service line growth, patient retention, accreditation readiness, and research initiatives.
